The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

R. Brahmer, Julie; Govindan, Ramaswamy; A. Anders, Robert; Antonia, Scott; Sagorsky, Sarah; Davies, Marianne; M. Dubinett, Steven; Ferris, Andrea; Gandhi, Leena; B. Garon, Edward; D. Hellmann, Matthew; R. Hirsch, Fred; Malik, Shakuntala; W. Neal, Joel; A. Papadimitrakopoulou, Vassiliki; L. Rimm, David; H. Schwartz, Lawrence; Sepesi, Boris; Y. Yeap, Beow; A. Rizvi, Naiyer; S. Herbst, Roy

doi:10.1186/s40425-018-0382-2

Public

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Published in Journal for ImmunoTherapy of Cancer • Jul 16, 2018

Authors:

Julie R. Brahmer

Ramaswamy Govindan

Robert A. Anders

Abstract

Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy - characterized by some benefit but only rare durable responses - was the only treatment option for patients with NSCLC w...

Subject

Medicine

Atezolizumab

Pembrolizumab

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!